Low CD8+ T-lymphocyte fraction and high stroma fraction combined with high-risk clinicopathological parameters can identify a very poor prognostic subgroup CRC with 5-year TTR of only 29% and 5-year overall survival of 42%. The gene discussed is CD8A; the disease is colorectal carcinoma.